Federal Trade Commission sues largest drug middlemen for …
WEBSep 20, 2024 · The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that...
Explainer: Why are US pharmacy benefit managers under fire?
WEBWASHINGTON, Sept 20 (Reuters) - The U.S. Federal Trade Commission said on Friday it was suing the country's three largest pharmacy benefit managers, accusing them of abusing their power and rigging...
FTC Sues Prescription Drug Middlemen for Artificially Inflating …
WEBSep 20, 2024 · Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group pur.
FTC Deepens Inquiry into Prescription Drug Middlemen
WEBMay 17, 2023 · As part of its ongoing inquiry into pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs, the Federal Trade Commission has issu.
Why PBMs, or pharmacy benefit managers, are the focus of new ... - NPR
WEBJul 7, 2023 · At least nine bills introduced in Congress take aim at pharmacy benefit managers, the powerful middlemen that channel prescription drugs to patients. Here's what the fuss is all about.
Lawmakers unveil PBM reform bill amid rising drug costs
WEBJul 23, 2024 · Bipartisan lawmakers introduced a new bill on Tuesday that aims to crack down on the business practices of drug supply chain middlemen who are widely accused of inflating prescription medication...
Federal Trade Commission accuses three drug middlemen of …
WEBSep 21, 2024 · The FTC accused the "Big Three" pharmacy benefit managers (PBMs) — UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts — of "engaging in anticompetitive and unfair...
FTC Releases Interim Staff Report on Prescription Drug Middlemen
WEBThe Federal Trade Commission today published an interim report on the prescription drug middleman industry that underscores the impact pharmacy benefit managers (PBMs) have on the accessibility and affordability of prescription drugs.
F.T.C. Slams Middlemen for High Drug Prices - The New York Times
WEBJul 9, 2024 · The Federal Trade Commission on Tuesday sharply criticized pharmacy benefit managers, saying in a scathing 71-page report that “these powerful middlemen may be profiting by inflating drug costs...
Why are US pharmacy benefit managers under fire? | Reuters
WEBWASHINGTON, April 16 (Reuters) - Pharmacy benefit managers (PBMs) are in the crosshairs of Republicans and Democrats in Congress but have so far dodged any new litigation or reforms that had been...